Skip to content
Home/Companies/Biotech/Integragen
Integragen

Integragen

Biotech·France·Exited 2020·Held 10yr
Entry
2010
Hold
10yr
Exit
2020

Who owns Integragen?

Integragen was owned by Generis Capital Partners through FPCI Entreprise & Croissance I (2018 vintage) from 2010 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-10

Generis Capital Partners
Investor
Generis Capital Partners
FPCI Entreprise & Croissance I · 2018 · Growth

Key facts

HQFrance
SectorBiotech
StatusAcquired
Websiteintegragen.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from FPCI Entreprise & Croissance I

Other portfolio companies in the same fund.

Alsea
Active
IndustrialsFrance· 2026
D&FI Groupe
Active
LogisticsFrance· 2026
Antoli
Antoli
Active
Business ServicesFrance· 2025
APEX Digital
Active
MedTechFrance· 2025
Luquet & Duranton
Luquet & Duranton
Active
Business ServicesFrance· 2025
Semco
Active
IndustrialsFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Integragen

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Integragen.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue